ABSTRACT
Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs. Low-activity phenotypes are correlated with several mutations in the TPMT gene. Polymorphisms of TPMT have been reported for Caucasians, African-Americans and Asians. Since ethnic differences have been demonstrated worldwide, it remains to be elucidated in Brazil. The Brazilian population is the result of five centuries of interethnic crosses between peoples from almost all continents as well as autochthonous Amerindians, all forming the fifth largest and one of the most heterogeneous populations in the world. The frequency of six allelic variants of the TPMT gene, *2 (G238C) (2.2%), *3A (G460A and A719G) (1.5%), *3B (G460A) (0.2%), *3C (A719G) (1.0%), *5 (0%) and *6 (0%) were determined in Brazilian subjects using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. This study provides the first analysis of TPMT mutant allele frequency in a sample of the Brazilian population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- ALL:
-
acute lymphoblastic leukemia
- 6-MP:
-
6-mercatopurine
- TPMT S-adenosyl L-methionine::
-
thiopurine S-methyltransferase
References
Kuks JB, Djojoatmodjo S, Oosterhuis HJ . Azathioprine in myasthenia gravis: observations in 41 patients and a review of literature. Neuromuscul Disord 1991; 1: 423–431.
Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999; 91: 2001–2008.
McLeod HL, Pritchard SC, Githang'a J, Indalo A, Ameyaw MM, Powrie RH et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 1999; 9: 773–776.
Langley P, Underhill J, Tredger J, Norris S, McFarlane I . Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J Hepatol 2002; 37: 441–447.
Pisetsky DS, St Clair EW . Progress in the treatment of rheumatoid arthritis. JAMA 2001; 286: 2787–2790.
Krynetski EY, Tai HL, Yates CR, Fessing MY, Loennechen T, Schuetz JD et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 1996; 6: 279–290.
Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996; 15: 17–30.
Seki T, Tanaka T, Nakamura Y . Genomic structure and multiple single-nucleotide polymorphisms (SNPs) of the thiopurine S-methyltransferase (TPMT) gene. J Hum Genet 2000; 45: 299–302.
Weinshilboum RM, Sladek SL . Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651–662.
McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE . Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994; 55: 15–20.
Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608–614.
Evans WE, Hon YY, Bomgaars L, Coutre S, Holdsworth M, Janco R et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol 2001; 19: 2293–22301.
McLeod HL, Siva C . The thiopurine S-methyltransferase gene locus–implications for clinical pharmacogenomics. Pharmacogenomics 2002; 3: 89–98.
Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE . A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci USA 1995; 92: 949–953.
Tai HL, Krynetski EY, Schuetz EG, Yanishevski Y, Evans WE . Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci USA 1997; 94: 6444–6449.
Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 1997; 62: 60–73.
Tai HL, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996; 58: 694–702.
Schutz E, Gummert J, Mohr F, Oellerich M . Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341: 436.
Weinshilboum RM, Raymond FA, Pazmino PA . Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1978; 85: 323–333.
Lennard L, Chew TS, Lilleyman JS . Human thiopurine methyltransferase activity varies with red blood cell age. Br J Clin Pharmacol 2001; 52: 539–546.
Spire-Vayron de la Moureyre C, Debuysere H, Mastain B, Vinner E, Marez D, Lo Guidice JM et al. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 1998; 125: 879–887.
Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE . Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 1999; 8: 371–376.
Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL . Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 1999; 8: 367–370.
Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999; 9: 37–42.
Alves S, Prata MJ, Ferreira F, Amorim A . Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal. Pharmacogenetics 1999; 9: 257–261.
McLeod HL, Coulthard S, Thomas AE, Pritchard SC, King DJ, Richards SM et al. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol 1999; 105: 696–700.
Rossi AM, Bianchi M, Guarnieri C, Barale R, Pacifici GM . Genotype–phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol 2001; 57: 51–54.
Lowenthal A, Meyerstein N, Ben-Zvi Z . Thiopurine methyltransferase activity in the Jewish population of Israel. Eur J Clin Pharmacol 2001; 57: 43–46.
Chang JG, Lee LS, Chen CM, Shih MC, Wu MC, Tsai FJ et al. Molecular analysis of thiopurine S-methyltransferase alleles in South-East Asian populations. Pharmacogenetics 2002; 12: 191–195.
Loennechen T, Utsi E, Hartz I, Lysaa R, Kildalsen H, Aarbakke J . Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway. Clin Pharmacol Ther 2001; 70: 183–188.
Kubota T, Chiba K . Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus. Br J Clin Pharmacol 2001; 51: 475–477.
Menor C, Fueyo J, Escribano O, Pina MJ, Redondo P, Cara C et al. Thiopurine methyltransferase activity in a Spanish population sample: decrease of enzymatic activity in multiple sclerosis patients. Multiple Sclerosis 2002; 8: 243–248.
Kham SK, Tan PL, Tay AH, Heng CK, Yeoh AE, Quah TC . Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2002; 24: 353–359.
Nishida A, Kubota T, Yamada Y, Higashi K, Kitamura K, Nakahara K et al. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes. Clin Chim Acta 2002; 323: 147–150.
Alves-Silva J, da Silva Santos M, Guimaraes PE, Ferreira AC, Bandelt HJ, Pena SD et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 2000; 67: 444–461.
Carvalho-Silva DR, Santos FR, Rocha J, Pena SD . The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 2001; 68: 281–286.
Chocair PR, Duley JA, Sabbaga E, Arap S, Simmonds HA, Cameron JS . Fast and slow methylators: do racial differences influence risk of allograft rejection? Q J Med 1993; 86: 359–363.
Rego EM, Garcia AB, Viana SR, Falcao RP . Characterization of acute lymphoblastic leukemia subtypes in Brazilian patients. Leukemia Res 1996; 20: 349–355.
McLeod HL, Krynetski EY, Relling MV, Evans WE . Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 567–572.
Tavadia SM, Mydlarski PR, Reis MD, Mittmann N, Pinkerton PH, Shear N et al. Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case. J Am Acad Dermatol 2000; 42: 628–632.
Senior PA, Bophal R . Ethnicity as a variable in epidemiological research. BMJ 1994; 309: 327–330.
Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD . Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003; 100: 177–182.
Acknowledgements
We thank Dr SD Pena for reading the manuscript and Ms Adriana Moreira for technical assistance. This work was supported by CNPq, Brazil (Grant # 550835/01).
Author information
Authors and Affiliations
Corresponding author
Additional information
DUALITY OF INTEREST
None declared.
Rights and permissions
About this article
Cite this article
Boson, W., Romano-Silva, M., Correa, H. et al. Thiopurine methyltransferase polymorphisms in a Brazilian population. Pharmacogenomics J 3, 178–182 (2003). https://doi.org/10.1038/sj.tpj.6500175
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500175
Keywords
This article is cited by
-
Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia
BMC Cancer (2014)
-
Thiopurine S-methyltransferase (TPMT) Activity Is Better Determined by Biochemical Assay Versus Genotyping in the Jewish Population
Digestive Diseases and Sciences (2014)
-
Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia
Medical Oncology (2013)
-
Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population
European Journal of Clinical Pharmacology (2010)
-
Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine
Medical Oncology (2010)